Skip to main content
Log in

Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

This study aimed to evaluate the prevalence of vertebral fractures to investigate the determinants of vertebral fracture risk in patients with COPD. The risk of vertebral fractures is strictly related to the severity of the disease. The use of glucocorticoids and the presence of low values of quantitative ultrasound (QUS) may represent additional risk factors.

Introduction

Chronic obstructive pulmonary disease (COPD) appears to be associated with osteoporosis. Our study aimed to evaluate the prevalence of vertebral fractures and to investigate the main determinants of vertebral fracture risk in patients with COPD.

Methods

In 3,030 ambulatory COPD patients (1,778 men and 1,262 women) aged 50 years or over, we evaluated: COPD severity, presence of vertebral fractures on lateral chest X-ray and bone status by using a quantitative ultrasound device.

Results

In men there was a strong association between COPD severity and fractures (p < 0.001), conversely in women the association between COPD severity and fractures was at limit (p = 0.049). In men, but not in women, glucocorticoid treatment was significantly associated with vertebral fractures. The patients with high or moderate risk of osteoporosis presented an increased risk of vertebral fracture (OR 2.71; 95% CI 2.04–3.60 and OR 1.54; 95% CI 1.26–1.88, respectively). Logistic regression analysis showed that COPD severity and glucocorticoid treatment, both inhaled and oral, were associated with increased risk of vertebral fractures.

Conclusion

In COPD patients the risk of vertebral fractures is strictly related to the severity of the disease. The use of glucocorticoids and reduced QUS at calcaneous may represent additional risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Rabe KF, Hurd S, Anzueto A et al (2007) Global initiative for chronic obstructive lung disease global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 15(176):532–555

    Article  Google Scholar 

  2. Wouters EF, Celis MP, Breyer MK et al (2007) Co-morbid manifestations in COPD. Respir Med: COPD update 3:135–151

    Article  Google Scholar 

  3. Biskobing DM (2002) COPD and osteoporosis. Chest 121:609–620

    Article  PubMed  Google Scholar 

  4. Ionescu AA, Schoon E (2003) Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J 22(Suppl 46):64s–75s

    Article  Google Scholar 

  5. Gluck O, Colice G (2004) Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases. Chest 125:1859–1876

    Article  PubMed  Google Scholar 

  6. Praet JP, Peretz A, Rozenberg S et al (1992) Risk of osteoporosis in men with chronic bronchitis. Osteoporos Int 2:257–261

    Article  PubMed  CAS  Google Scholar 

  7. Iqbal F, Michaelson J, Thaler L et al (1999) Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 116:1616–1624

    Article  PubMed  CAS  Google Scholar 

  8. Van Staa TP, Leufkens HG, Abenhaim L et al (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000

    Article  PubMed  Google Scholar 

  9. The Lung Health Study Research Group (2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 343:1902–1909

    Article  Google Scholar 

  10. Pauwels RA, Löfdahl CG, Laitinen LA et al (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society study on chronic obstructive pulmonary disease. N Engl J Med 340:1948–1953

    Article  PubMed  CAS  Google Scholar 

  11. Sosa M, Saavedra P, Valero C, GIUMO Study Group et al (2006) Inhaled steroids do not decrease bone mineral density but increase risk of fractures: data from the GIUMO Study Group. J Clin Densitom 9:154–158

    Article  PubMed  CAS  Google Scholar 

  12. Kjensli A, Mowinckel P, Ryg MS et al (2007) Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone 40:493–497

    Article  PubMed  CAS  Google Scholar 

  13. Vrieze A, de Greef MH, Wijkstra PJ et al (2007) Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int 18:1197–1202

    Article  PubMed  CAS  Google Scholar 

  14. Katsura H, Kida K (2002) A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 122:1949–1955

    Article  PubMed  Google Scholar 

  15. Incalzi RA, Caradonna P, Ranieri P et al (2000) Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 94:1079–1084

    Article  PubMed  CAS  Google Scholar 

  16. Dimai HP, Domej W, Leb G et al (2001) Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia. J Bone Miner Res 16:2132–2141

    Article  PubMed  CAS  Google Scholar 

  17. Vermeeren MA, Creutzberg EC, Schols AM, on behalf of the COSMIC Study Group et al (2006) Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 100:1349–1355

    Article  PubMed  CAS  Google Scholar 

  18. Papaioannou A, Parkinson W, Ferko N et al (2003) Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int 14:913–917

    Article  PubMed  CAS  Google Scholar 

  19. Schlaich C, Minne HW, Bruckner T et al (1998) Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int 8:261–267

    Article  PubMed  CAS  Google Scholar 

  20. Kado DM, Browner WS, Palermo L et al (1999) Vertebral fractures and mortality in older women: a prospective study. Study of osteoporotic fractures research group. Arch Intern Med 159:1215–1220

    Article  PubMed  CAS  Google Scholar 

  21. Riancho JA, Gonzalez Macias J, Del Arco C et al (1987) Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. Thorax 42:962–966

    Article  PubMed  CAS  Google Scholar 

  22. McEvoy CE, Ensrud KE, Bender E et al (1998) Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:704–709

    PubMed  CAS  Google Scholar 

  23. de Vries F, van Staa TP, Bracke MS et al (2005) Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 25:879–884

    Article  PubMed  Google Scholar 

  24. Jørgensen NR, Schwarz P, Holme I et al (2007) The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 101:177–185

    Article  PubMed  Google Scholar 

  25. de Vries F, Bracke M, Leufkens HG et al (2007) Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56:208–214

    Article  PubMed  CAS  Google Scholar 

  26. Vestergaard P, Rejnmark L, Mosekilde L (2007) Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest 132:1599–1607

    Article  PubMed  CAS  Google Scholar 

  27. Guglielmi G, Stoppino LP, Placentino MG et al. (2007) Reproducibility of a semi-automatic method for 6-point vertebral morphometry in a multi-centre trial. Eur J Radiol. Published online December 8 doi:10.1016/j.ejrad.2007.09.040

  28. Genant HK, Wu CY, van Kuijk C et al (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148

    PubMed  CAS  Google Scholar 

  29. Krieg MA, Barkmann R, Gonnelli S et al (2008) Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom 11:163–187

    Article  PubMed  Google Scholar 

  30. O'Neill TW, Felsenberg D, Varlow J et al (1996) The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1018

    Article  PubMed  Google Scholar 

  31. Angeli A, Guglielmi G, Dovio A et al (2006) High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39:253–259

    Article  PubMed  CAS  Google Scholar 

  32. Lekamwasam S, Trivedi DP, Khaw KT (2002) An association between respiratory function and bone mineral density in women from the general community: a cross sectional study. Osteoporos Int 13:710–715

    Article  PubMed  CAS  Google Scholar 

  33. Bonnet N, Benhamou CL, Brunet-Imbault B et al (2005) Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone 37:622–633

    Article  PubMed  CAS  Google Scholar 

  34. de Vries F, Pouwels S, Bracke M et al (2007) Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study. Pharmacoepidemiol Drug Saf 16:612–619

    Article  PubMed  CAS  Google Scholar 

  35. Vestergaard P, Rejnmark L, Mosekilde L et al (2007) Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest 132:1599–607

    Article  PubMed  CAS  Google Scholar 

  36. van Staa TP, Leufkens HG, Cooper C (2001) Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res 16:581–588

    Article  PubMed  Google Scholar 

  37. de Vries F, Pouwels S, Lammers JW et al (2007) Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study. J Intern Med 261:170–177

    PubMed  Google Scholar 

  38. Huopio J, Kröger H, Honkanen R et al (2004) Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporos Int 15:190–195

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Preliminary results of this study were partly reported as poster presentation at the 29th Annual Meeting at the American Society for Bone and Mineral Research, September 16–19 2007—Honolulu, USA.

The Evaluation of Obstructive Lung disease and Osteoporosis (EOLO) study group includes the following (all in Italy): Angeli A, De Rose V, Orbassano (TO); Cravero M, Fantino S, Torino; Isaia G, Baldi S, Torino; Cisari C, Ronco M, Novara; Rocchetta PA, Polla B, Alessandria; Mondavio M, Ferraro G, Acqui Terme (AL); Bianchi G, Bonaria M, Arenzano (GE); Versace F, Vacca N, Savona; Calitro M, Iaffaldano A, Canosa di Puglia (BA); Muratore M, Mandurino L, S. Cesareo di Lecce (LE); Maugeri D, Distefano S, Catania; Fiore CE, Di Maria G, Catania; Frisina N, Girbino G, Messina; Rossetto S, Rossetto G, Piazza Armerina (EN); Pedrazzoni M, Cuomo A, Parma; Trotta Francesco, Potena A, Ferrara; Biondi M, Fiorentini F, Forlì; Malavolta N, Fagiani A, Bologna; Del Forno L, Colaneri A, Vasto (CH); De Felice A, De Matthaeis G, Lanciano (CH); Di Matteo L, Cortese G, Pescara; Mancini G, Tubaldi A. Macerata; Pozone M, Fiore Donati A, L’Aquila; Sfrappini M, Olori G, S. benedetto del Tronto (AP); Silveri F, Subiaco S, Jesi (AN); Latte VM, Ricciardi C, Napoli; Noverino L, Tallarico L, Napoli; Del Puente A, Zedda A, Napoli; Borg MJ, Longobardi U, Napoli; Cerqua R, Califano M, San Felice a Cancello (CE); Aversa A, Battaglia E, Milano; Santi I, Caratozzolo O, Milano; Tenca P, Davoli C, Bosio G, Cremona; Cavaiani P, Alessandrini A, Abbiategrasso (MI); Rondena M, Grechi A, Legnano; Galimberti G, Ciccarelli M, Rozzano (MI); Giustina A, Cantucci C, Brescia; Giannini S, Zuin R, Padova; Bertoldo F, Ferrari M, Verona; Adami S, Cipriani A, Valeggio (VR); Bortolotti R, Sella D, Trento; Schinella D, Mazza F, Pordenone; Di Virgilio R, Santelli G, Treviso; Tartarelli G, Vincenti R, Massa; Bertolucci D, Torrini A, Lido di Camaiore (LU); Di Munno O, Paggiaro P, Pisa; Sabadini L, Naldi M, Arezzo; Brandi ML, Pistoleri M, Firenze; Nuti R, Frediani B, Rottoli P, Siena; Cecchetti R, Faloppa C, Pontedera (PI); Bancheri C, Trequatrini T, Roma; Falaschi P, Mariotta S, Roma; Napoletano C, Dominaci M, Latina.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Gonnelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nuti, R., Siviero, P., Maggi, S. et al. Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study. Osteoporos Int 20, 989–998 (2009). https://doi.org/10.1007/s00198-008-0770-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-008-0770-4

Keywords

Navigation